Transfer factor in chronic mucocutaneous candidiasis

Biotherapy ◽  
1996 ◽  
Vol 9 (1-3) ◽  
pp. 97-103 ◽  
Author(s):  
Massimo Masi ◽  
Caterina De Vinci ◽  
Olavio Roberto Baricordi
1976 ◽  
Vol 38 (3) ◽  
pp. 413-417
Author(s):  
Tadahiko MATSUMOTO ◽  
Midori ISODA ◽  
Kunisuke HIMENO

PEDIATRICS ◽  
1974 ◽  
Vol 53 (1) ◽  
pp. 63-70
Author(s):  
Ralph D. Feigin ◽  
Penelope G. Shackelford ◽  
Seth Eisen ◽  
Lynn E. Spitler ◽  
Larry K. Pickering ◽  
...  

Evaluation of a patient with chronic mucocutaneous candidiasis revealed that the patient lacked delayed hypersensitivity to candida and other skin test antigens and the patient's lymphocytes could not be stimulated in vitro with candida antigen. Phytohemagglutinin stimulation of lymphocytes in vitro was normal. Candidacidal function and myeloperoxidase activity of the patient's leukocytes were normal. The patient's lymphocytes produced migration inhibitory factor in response to candida antigen and the monocyte receptor sites for IgG were intact. Repeated treatments with amphotericin B, alone or with 5-fluorocytosine, were followed by immediate relapse. Four doses of transfer factor were administered and when coupled with amphotericin B on two occasions prompted remissions of 6 and 4 months, respectively.


Sign in / Sign up

Export Citation Format

Share Document